WV
Wave Life Sciences Ltd.
WVE · NASDAQ
$4.44 -3.16% (-$0.14)
1M -18.08%
Market Cap $874.9M
P/E Ratio -
Div. Yield -
ROE 50.12%
Piotroski F-Score Weak
3/9Valuation
45 /100
Fair P/B 1.93x
P/S 13.38x
EV/EBITDA N/A
Growth
100 /100
Growing Rev. growth 127.08%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 309.73%
Op. margin 333.36%
FCF margin 284.90%
Quality
2 /100
Poor ROE 50.12%
ROA 36.26%
Asset turnover 0.12x
Debt
100 /100
Low Current ratio 9.99x
Debt/Equity 0.10x
Net debt/EBITDA N/A
Stability
15 /100
Unstable Rev. volatility 1,753.97%
EPS volatility 75.28%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre WVE
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Paul Bolno
Employees
317
Headquarters
Cambridge
Evenimente viitoare
09 NOV.
Earnings
Upcoming earnings report